Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flecainide vs Amiodarone for AF Cardioversion in CAD Patients
NCT05549752Phase 3Recruiting
- Sponsor
- Hippocration General Hospital
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flecainide in Atrial fibrillation (AFib), sponsored by Hippocration General Hospital. Started Mar 2023; status: recruiting.
02
Drugs
flecainide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05549752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05549752.